Results 181 to 190 of about 6,341,126 (268)

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Repair Bond Strength of Milled and 3D-Printed CAD/CAM Hybrid Materials Using Different Repair Protocols: An In Vitro Study. [PDF]

Clin Exp Dent Res
Milicevic M, Beuer F, Henning N, Yassine J, Schmidt F, Rechlin J, Prause E.   +6 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Effects of different polishing and glazing systems on the physical properties of ceramics. [PDF]

BMC Oral Health
Gökay GD, Şenol M, Oyar P, Gürbüz A.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Advanced Plasma-Modified Textile Polymer Materials for Building Energy Retrofit Technologies. [PDF]

Polymers (Basel)
Azeem M, Amor N, Kashif M, Noman MT.
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Pioneering next-generation bioactive materials for endodontics: Insights of mitochondrial biology. [PDF]

Bioact Mater
Cheng S, Liu XY, Zhou L, Mao HQ, Wen YH, Meng X, Zhang L, Chen Z.   +7 more
europepmc   +1 more source

High-throughput discovery of Li₃Sc₂(PO₄)₃ as a protective coating for stabilizing mid-Ni NCM interfaces in all-solid-state batteries. [PDF]

Nano Converg
Kim JH, Lee S, Lee SU.
europepmc   +1 more source

Influence of two pediatric multivitamin forms on surface characteristics and color stability of single-shade composite, nanofilled composite, and glass ionomer cement: an in vitro study. [PDF]

BMC Oral Health
Elbatanony MM, El Shahawi AM, Zaki DY.
europepmc   +1 more source